Unintentional injuries in Mexico, 1990-2017: findings from the Global Burden of Disease Study 2017.


Journal

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention
ISSN: 1475-5785
Titre abrégé: Inj Prev
Pays: England
ID NLM: 9510056

Informations de publication

Date de publication:
10 2020
Historique:
received: 14 10 2019
revised: 03 12 2019
accepted: 06 12 2019
pubmed: 3 4 2020
medline: 31 8 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

To date, the burden of injury in Mexico has not been comprehensively assessed using recent advances in population health research, including those in the Global Burden of Disease Study 2017 (GBD 2017). We used GBD 2017 for burden of unintentional injury estimates, including transport injuries, for Mexico and each state in Mexico from 1990 to 2017. We examined subnational variation, age patterns, sex differences and time trends for all injury burden metrics. Unintentional injury deaths in Mexico decreased from 45 363 deaths (44 662 to 46 038) in 1990 to 42 702 (41 439 to 43 745) in 2017, while age-standardised mortality rates decreased from 65.2 (64.4 to 66.1) in 1990 to 35.1 (34.1 to 36.0) per 100 000 in 2017. In terms of non-fatal outcomes, there were 3 120 211 (2 879 993 to 3 377 945) new injury cases in 1990, which increased to 5 234 214 (4 812 615 to 5 701 669) new cases of injury in 2017. We estimated 2 761 957 (2 676 267 to 2 859 777) disability-adjusted life years (DALYs) due to injuries in Mexico in 1990 compared with 2 376 952 (2 224 588 to 2 551 004) DALYs in 2017. We found subnational variation in health loss across Mexico's states, including concentrated burden in Tabasco, Chihuahua and Zacatecas. In Mexico, from 1990 to 2017, mortality due to unintentional injuries has decreased, while non-fatal incident cases have increased. However, unintentional injuries continue to cause considerable mortality and morbidity, with patterns that vary by state, age, sex and year. Future research should focus on targeted interventions to decrease injury burden in high-risk populations.

Sections du résumé

BACKGROUND
To date, the burden of injury in Mexico has not been comprehensively assessed using recent advances in population health research, including those in the Global Burden of Disease Study 2017 (GBD 2017).
METHODS
We used GBD 2017 for burden of unintentional injury estimates, including transport injuries, for Mexico and each state in Mexico from 1990 to 2017. We examined subnational variation, age patterns, sex differences and time trends for all injury burden metrics.
RESULTS
Unintentional injury deaths in Mexico decreased from 45 363 deaths (44 662 to 46 038) in 1990 to 42 702 (41 439 to 43 745) in 2017, while age-standardised mortality rates decreased from 65.2 (64.4 to 66.1) in 1990 to 35.1 (34.1 to 36.0) per 100 000 in 2017. In terms of non-fatal outcomes, there were 3 120 211 (2 879 993 to 3 377 945) new injury cases in 1990, which increased to 5 234 214 (4 812 615 to 5 701 669) new cases of injury in 2017. We estimated 2 761 957 (2 676 267 to 2 859 777) disability-adjusted life years (DALYs) due to injuries in Mexico in 1990 compared with 2 376 952 (2 224 588 to 2 551 004) DALYs in 2017. We found subnational variation in health loss across Mexico's states, including concentrated burden in Tabasco, Chihuahua and Zacatecas.
CONCLUSIONS
In Mexico, from 1990 to 2017, mortality due to unintentional injuries has decreased, while non-fatal incident cases have increased. However, unintentional injuries continue to cause considerable mortality and morbidity, with patterns that vary by state, age, sex and year. Future research should focus on targeted interventions to decrease injury burden in high-risk populations.

Identifiants

pubmed: 32238437
pii: injuryprev-2019-043532
doi: 10.1136/injuryprev-2019-043532
pmc: PMC7571365
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

i154-i161

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: SLJ works in an influenza/RSV grant that is funded by Sanofi Pasteur.

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Lancet Glob Health. 2015 Nov;3(11):e712-23
pubmed: 26475018
Gac Med Mex. 2012 Jul-Aug;148(4):349-57
pubmed: 22976753
Gac Sanit. 2020 Nov - Dec;34(6):572-581
pubmed: 31300326
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Bull World Health Organ. 2009 Jul;87(7):542-8
pubmed: 19649369
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Popul Health Metr. 2012 Jan 06;10:1
pubmed: 22226226
Rev Panam Salud Publica. 2007 Jun;21(6):373-80
pubmed: 17761049
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
Inj Prev. 2005 Feb;11(1):24-8
pubmed: 15691985
Int J Inj Contr Saf Promot. 2010 Sep;17(3):169-76
pubmed: 20182934
Rev Saude Publica. 2018 Jul 23;52:67
pubmed: 30043954
Lancet Neurol. 2019 Jan;18(1):56-87
pubmed: 30497965
Lancet. 2016 Dec 10;388(10062):e19-e23
pubmed: 27371184
Injury. 2001 May;32(4):279-84
pubmed: 11325362
Addiction. 1998 Oct;93(10):1543-51
pubmed: 9926559
Inj Control Saf Promot. 2003 Mar-Jun;10(1-2):37-43
pubmed: 12772484
Public Health Rep. 2005 Nov-Dec;120(6):598-600
pubmed: 16350328
Gerontologist. 2016 Dec 7;57(2):153-162
pubmed: 27927730
Lancet Glob Health. 2018 May;6(5):e523-e534
pubmed: 29653626
Lancet. 2018 Nov 10;392(10159):1995-2051
pubmed: 30496106
Popul Health Metr. 2016 Apr 28;14:14
pubmed: 27127419

Auteurs

Martha Híjar (M)

Research Coordination, AC Environments Foundation, Cuernavaca, Mexico.
CISS, National Institute of Public Health, Cuernavaca, Mexico.

Ricardo Pérez-Núñez (R)

Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico.

Elisa Hidalgo-Solórzano (E)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Bernardo Hernández Prado (B)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.

Rosario Valdez-Santiago (R)

CISS, National Institute of Public Health, Cuernavaca, Mexico.

Erin B Hamilton (EB)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Spencer L James (SL)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA spencj@uw.edu.

Gregory J Bertolacci (GJ)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Matthew Cunningham (M)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Zachary V Dingels (ZV)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Jack T Fox (JT)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Zichen Liu (Z)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Nicholas L S Roberts (NLS)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Dillon O Sylte (DO)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Marcela Agudelo-Botero (M)

School of Medicine, Center for Politics, Population and Health Research, National Autonomous University of Mexico, Mexico City, Mexico.

Guilherme Borges (G)

Department of Epidemiology and Psychosocial Research, Ramón de la Fuente Muñiz National Institute of Psychiatry, Mexico City, Mexico.

Lucero Cahuana-Hurtado (L)

Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico.

Ismael R Campos-Nonato (IR)

National Institute of Public Health, Cuernavaca, Mexico.

Rosario Cárdenas (R)

Department of Population and Health, Metropolitan Autonomous University, Mexico City, Mexico.

Claudio Alberto Dávila-Cervantes (CA)

Population and Development, Facultad Latinoamericana de Ciencias Sociales Mexico, Mexico City, Mexico.

Edgar Denova-Gutiérrez (E)

Center for Nutrition and Health Research, National Institute of Public Health, Cuernavaca, Mexico.

Daniel Diaz (D)

Center of Complexity Sciences, National Autonomous University of Mexico, Mexico City, Mexico.
Facultad de Medicina Veterinaria y Zootecnia, Autonomous University of Sinaloa, Culiacan Rosales, Mexico.

Van C Lansingh (VC)

HelpMeSee, New York, NY, USA.
International Relations, Mexican Institute of Ophthalmology, Queretaro, Mexico.

Gabriel Martinez (G)

Department of Economics, Autonomous Technology Institute of Mexico, Mexico City, Mexico.

Pablo A Montero-Zamora (PA)

Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico.
Department of Public Health Sciences, University of Miami, Miami, FL, USA.

Edson Serván-Mori (E)

Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico.

Rafael Lozano (R)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH